Industry Voice Calls for Alcohol-Style Hemp Cannabinoid Regulation

State-Control Framework Proposed as Hemp Market Solution

The opinion piece advocates for a federally sanctioned, state-administered regulatory model that mirrors the three-tier alcohol system established after Prohibition. Under this framework, states would license hemp cannabinoid producers, distributors, and retailers while setting their own potency limits, packaging requirements, and taxation structures.

The proposal comes as hemp-derived cannabinoid products—including delta-8 THC, THCA, and delta-10 THC—face mounting regulatory uncertainty. The 2018 Farm Bill legalized hemp containing less than 0.3 percent delta-9 THC. It didn't address intoxicating cannabinoids synthesized or extracted from legal hemp biomass.

Federal agencies have yet to issue comprehensive guidance. The DEA's interim final rule on hemp extracts remains contested, and FDA enforcement actions against hemp-derived CBD products haven't extended to newer intoxicating cannabinoids sold in gas stations and smoke shops across most states.

Alcohol Precedent Offers Regulatory Blueprint

The Twenty-First Amendment granted states primary authority over alcohol distribution and sales after the repeal of Prohibition in 1933, creating a tested framework for managing intoxicating substances. Proponents argue this model balances public health concerns with economic opportunity.

Key features of the alcohol model include:

• State licensing of producers, wholesalers, and retailers
• Local option rules allowing counties or municipalities to ban sales
• Age restrictions and ID verification requirements
• Excise taxes funding enforcement and public health programs
• Product testing and labeling standards

Seventeen states currently operate government-run liquor stores or control wholesale distribution. Others rely on private licensees under state oversight.

Volatile Market Threatens Hemp Farmers

Hemp biomass prices have collapsed from $40 per pound in 2019 to under $1 per pound in 2026 as overproduction and regulatory uncertainty flood the market. Thousands of farmers who planted hemp after the 2018 Farm Bill legalized cultivation now face unsold inventory and mounting debt.

A stable regulatory framework would restore market confidence, the opinion argues. Processors and retailers hesitate to sign long-term contracts with farmers when federal enforcement actions or state bans could eliminate their customer base overnight.

USDA data shows hemp acreage dropped 31 percent between 2021 and 2025. Licensed growers declined from 16,877 in 2021 to 9,240 in 2025. Most remaining operations cultivate for fiber or grain, not cannabinoid extraction.

State Patchwork Creates Compliance Chaos

Eighteen states have banned delta-8 THC and similar hemp cannabinoids, while others impose varying potency caps, testing mandates, and sales restrictions. Interstate commerce remains legal under the 2018 Farm Bill. Enforcement varies widely.

States with bans or restrictions include:

• Colorado: banned delta-8 and delta-10 THC in 2023
• New York: requires Cannabinoid Hemp licensure; caps THC at 0.3% per package
• Oregon: prohibits artificially derived cannabinoids
• Vermont: bans all intoxicating hemp products
• Montana: emergency rule banning delta-8 issued in 2021, extended annually

Manufacturers face conflicting lab testing protocols. Some states require only delta-9 THC measurement; others demand full cannabinoid panels including THCA, delta-8, and HHC.

Tax Revenue Potential Mirrors Early Cannabis Markets

Colorado collected $423 million in marijuana excise taxes in fiscal 2025; proponents argue hemp cannabinoid taxation could generate comparable revenue if legalized and regulated at scale. The opinion suggests earmarking tax proceeds for rural development, substance abuse treatment, and agricultural research.

California's cannabis excise tax generated $1.1 billion in 2025 despite a large illicit market. Illinois collected $445 million in adult-use cannabis taxes in its fifth year of legalization.

Hemp cannabinoid sales are difficult to track due to the unregulated market, but industry estimates place the sector between $2 billion and $8 billion annually. Most transactions occur in convenience stores, vape shops, and online retailers outside state tax systems.

Public Health Concerns Drive Opposition

Critics of loosely regulated hemp cannabinoids cite rising emergency room visits and poison control calls linked to high-potency edibles marketed without child-resistant packaging or dosage warnings. The American Association of Poison Control Centers reported 3,358 delta-8 THC exposure cases in 2025, up from 2,362 in 2024.

Pediatric cases accounted for 41 percent of exposures. Products shaped like candy or packaged in bright colors remain widely available despite voluntary industry guidelines issued by the U.S. Hemp Roundtable in 2023.

Since 2021, the FDA has issued over 100 warning letters to hemp cannabinoid manufacturers, primarily for unapproved health claims and mislabeling. The agency hasn't sought injunctions or criminal referrals, and most companies continue operating after removing specific claims from their websites.

Legislative Path Remains Unclear

No federal hemp cannabinoid legislation has advanced past committee in the current Congress, though at least four bills addressing intoxicating hemp products were introduced in 2025. The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, introduced by Rep. Chellie Pingree (D-Maine) and Rep. Mary Miller (R-Ill.), would authorize FDA to regulate hemp cannabinoids as dietary supplements with THC limits.

The Hemp Advancement Act of 2025, sponsored by Sen. Rand Paul (R-Ky.) and Sen. Ron Wyden (D-Ore.), would raise the legal THC threshold from 0.3 percent to 1 percent and preempt state bans on interstate hemp commerce. Neither bill has received a committee vote.

For full background on this story, see the CannIntel topic hub on Hemp Cannabinoid Regulation.

The next Farm Bill reauthorization is scheduled for 2028. Congressional aides told trade publications in May that hemp cannabinoid language is unlikely to be included in must-pass appropriations bills before then.